Ver­tex fi­nal­ly makes NICE with Eng­land's NHS on CF ther­a­pies, but runs in­to hic­cup with pre­clin­i­cal kid­ney drug da­ta

Days af­ter Ver­tex Phar­ma­ceu­ti­cals $VRTX se­cured a much ear­li­er-than-an­tic­i­pat­ed FDA ap­proval for its cys­tic fi­bro­sis cock­tail that cov­ers the ma­jor­i­ty of pa­tients — the drug­mak­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.